LBF20107PG22

LipidBank Top (トップ)

Fatty acid (脂肪酸)

Glycerolipid (グリセロ脂質)

Sphingolipid (スフィンゴ脂質)

Journals (雑誌一覧)

How to edit (ページの書き方)

Upper classes: LB LBF

IDs and Links
LipidBank	XPR1738
LipidMaps	LMFA03010056
CAS
KEGG	{{{KEGG}}}
KNApSAcK	{{{KNApSAcK}}}
mol	LBF20107PG22

15S-15-methyl Prostaglandin E1
Structural Information
Systematic Name	9-Oxo- (11α,15S) -dihydroxy-15-methyl-prost-13-trans-en-1-oic acid
Common Name	15S-15-methyl Prostaglandin E1 9-Oxo- (11α,15S) -dihydroxy-15-methylprost-13(E)-en-1-oic acid
Symbol
Formula	C21H36O5
Exact Mass	368.256274262
Average Mass	368.50754
SMILES	C(=C[C@H]([C@H]1CCCCCCC(O)=O)[C@@H](CC1=O)O)[C@](C)(O)CCCCC
Physicochemical Information
Melting Point
Boiling Point
Density
Optical Rotation
Refractive Index
Solubility
Source
Chemical Synthesis
Metabolism
Biological Activity	15(S)-15-methyl Prostaglandin E1 shows weak constriction effect on human respiratory tract smooth muscle. Karim_SM et al.15(S)-15-methyl Prostaglandin E1 at 300 ng/kg administered systemically (subcutaneously), selectively suppresses PMN-dependent edema formation. Rampart_M et al. In hamsters, 15(S)-15-methyl Prostaglandin E1 of 150 micrograms reduced the number of PMNLs adherent to blood vessels and infiltrating the ICT (infiltrated connective tissue) and other inflammation. Caillon_P et al.
Genetic Information
Note
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms

Reported Metabolites, References
Biospecies ID Compound Name Reference Comment n.a. LBF20107PG22 See above. Caillon_P et al. 1994 n.a. LBF20107PG22 See above. Karim_SM et al. 1980 n.a. LBF20107PG22 See above. Rampart_M et al. 1986